Categories: News

Hardy Diagnostics Presents: Detection of Carbapenemase Producing Organisms; Advancements and Barriers to the Clinical Laboratory

Free educational webinar hosted by Hardy Diagnostics offered with continuing education credits

Join!

Join!

SANTA MARIA, Calif., Sept. 21, 2021 (GLOBE NEWSWIRE) — Carbapenemase-resistant Enterobacterales (CRE) are a major concern for patients in health care facilities. Some bacteria in this family are resistant to nearly all antibiotics, leaving only more toxic or less effective treatment options.

To learn more about the utility of screening for Carbapenem-resistant Enterobacterales and the technologies that are available to do so, Hardy Diagnostics is pleased to offer a free webinar titled, “Detection of carbapenemase-producing organisms; advancements and barriers to the clinical lab,” on Oct. 7, 2021, at 11 a.m. PST/1 p.m. CST.

Led by Nathan Ledeboer, PhD, D(ABMM), F(AAM) this discussion will:

  • Discuss the utility of screening for CRE from clinical specimens.
  • Contrast the difference between carbapenemase-producing organisms with carbapenem-resistant organisms.
  • Evaluate technologies available to screen for carbapenemases from stool, rectal swabs and from bacterial colonies.
  • Discuss the pros and cons of implementing a CRE screening program.  

Dr. Nathan Ledeboer is a Professor and Vice Chair of Pathology at the Medical College of Wisconsin, and Medical Director of Microbiology, Molecular Diagnostics, reference services, and laboratory client services at Froedtert Hospital and Wisconsin Diagnostic Laboratories. He is also the editor of the Journal of Clinical Microbiology

This free webinar is presented by Hardy Diagnostics.

C.E. credits are offered in partnership through the Northern California Branch of the American Society of Microbiology (NCASM) LFS #400.

Click here to register for this educational webinar. For more information, contact Megan Roesner at roesnerm@hardydiagnostics.com.

To learn more about the products offered at Hardy Diagnostics to detect and diagnose disease, please visit www.hardydiagnostics.com.

Related Images

Image 1: Join!

This content was issued through the press release distribution service at Newswire.com.

Attachment

Staff

Recent Posts

This World Cancer Day, St. Baldrick’s Foundation Leads the Charge Against Childhood Cancer

Los Angeles, California--(Newsfile Corp. - February 4, 2026) - This World Cancer Day, the St.…

1 hour ago

The Leadership Shift Powering Doceree’s Next Chapter in the US: Kamya Elawadhi Announced as Co-Founder & President

Strategic elevation signals bold expansion as Doceree redefines healthcare marketing with AI-powered precision and purposeSHORT…

3 hours ago

Canvas Medical Named 2026 Best in KLAS for Ambulatory Specialty EHR

Next-generation EMR platform recognized for helping specialty practices deliver efficient, personalized patient careSAN FRANCISCO, Feb.…

3 hours ago

Kontakt.io Introduces Supply Chain AI to Transform Care Support Operations

Agentic AI integrates EHR and RTLS data to automate equipment workflows and improve operational efficiency,…

3 hours ago

Robotic Surgery Market Is No Longer a Technology Story. It Is a Discipline Test for Hospitals: MMR Statistics

PUNE, India, Feb. 4, 2026 /PRNewswire/ -- For nearly a decade, robotic surgery was sold as progress.…

3 hours ago

Champion Insights Officially Opens Enrollment to Investigate ALS Risk in High-Performance Athletes, Military Members, and First Responders

Ambitious nationwide study will enroll 500 participants to examine genetic, biological, and environmental factors linked…

3 hours ago